Moderna Hopes To Build On mRNA Tech Used In Its Covid Shots—By Targeting Genetic Diseases

Topline Moderna on Wednesday announced a new partnership with Life Edit Therapeutics geared towards finding and developing treatments for rare genetic diseases and other conditions, as the Massachuset...

This biotech stock could double from here: Goldman Sachs

Vir Biotechnology Inc (NASDAQ: VIR) jumped nearly 10% this morning after a Goldman Sachs analyst turned super bullish on the clinical-stage immunology company. Vir stock has upside to $53 a share On T...

JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics.

Johnson & Johnson recently increased an investment in an embattled biotech stock, and slashed a position in a maker of surgical robotics that rocketed last year. Johnson & Johnson (ticker: JNJ...

Canaccord loves these biotech stocks — and gives them upside of more than 80%

Biotech stocks give a whole new meaning to risk/reward plays. Unlike names inhabiting other areas of the market, these tickers can witness explosive movements in the blink of an eye, giving them a Str...

Google’s ex-CEO Eric Schmidt tapped for federal biotech commission that allows members to keep investments

On Dec. 30, leaders of the House and Senate Armed Services committees announced the selection of former Google CEO Eric Schmidt and 11 others to serve on a new federal commission on biotechnology. Tas...

Inscripta Is Reimagining What The Synthetic Biology Company Of The Future Will Be

Inscripta’s team in Pleasanton, CA Inscripta Inscripta, a global leader in genome engineering, is reshaping the image of a synthetic biology company. Biomanufacturing is set to transform many industri...

Ginkgo Bioworks Fires Up Its Bio Foundry To Take On The Billion-Dollar Enzyme Market

Ginkgo Bioworks banner on the façade of the New York Stock Exchange building. Ginkgo Bioworks Ginkgo Bioworks is getting ready for another year of disrupting the entire biotech industry model with its...

UBS reveals a biotech stock that can nearly double from here

Shares of CureVac BV (NASDAQ: CVAC) have already almost doubled year-to-date but a UBS analyst says the stock still has a lot more room to the upside. CureVac stock could gain close to 100% On Thursda...

7 Cheap But Risky Biotech Stocks

Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF drop nearly 50%. The other most-watched exchange-traded fund that tracks the biotech sector, the...

Top 10 Investment Themes For 2023

The overall theme for 2023 is “better days ahead.” getty My overall macro theme for 2022 was “still growing but yet slowing.” The theme proved to be relatively accurate, at lea...

Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...

How China’s Leading Female Healthcare Investor Backs Billion-Dollar Biotech Companies

As managing partner of Qiming Venture Partners, Nisa Leung has invested in over 30 of China’s healthcare giants. Underlying her prolific track record is her goal to solve as many incurable diseases as...

6 Favorite Biotech Bets For 2023

Biotechnology has often been among the most popular sectors in the MoneyShow Top Picks report, our annual survey of the nation’s leading newsletter advisors. This year’s report is no exception; here’s...

Jefferies analyst reveals his top two biotech stocks for 2023

Moderna Inc (NASDAQ: MRNA) has tanked nearly 15% in recent days but a Jefferies analyst dubs it one of his best ideas for 2023. Moderna stock could climb another 50% Earlier in December, the biotech c...

Top Stocks Hit New Highs As Egg Producer And Biotech Stock Exceed Buy Points

Egg producer Cal-Maine Foods (CALM) broke solidly into its buy zone Friday while biotech MannKind (MNKD) is near the top of its buy zone. Both stocks hit new highs this week in spite of the stock mark...

Biotech And Medical Stocks Leading Performers As 2022 Draws To A Close

A handful of biotech and medical stocks have joined the elite IBD 50 list, boasting strong fundamentals and high growth potential. These leading industry groups have proven winners booking double-digi...

Meet the Biotech Stock That Jumped Over 260% in One Day

Standard market action is of little interest to stocks operating in the biotech space that happen to post good news. Say, the market is taking a beating – a regular occurrence these days – and a biote...

I’m Going to Give This Biotech Another Shot

Dynavax Technologies (DVAX) has spent 2022 building up its cash balance as the biotech raked in revenues from its adjuvant that’s used by several Covid vaccine makers, primarily in Europe. In ad...

Elemental Machines Is Bringing The Internet Of Things To Lab Operations To Save Millions Of Dollars For Biotech Companies

Sridhar Iyengar, the founder and CEO of Elemental Machines. Elemental Machines The Internet of Things (IoT) products – like a Bluetooth speaker showerhead or refrigerator that orders things directly f...

Investing in These 2 Biotech Stocks Could Double Your Money, Says Analyst

Let’s talk about biotech. These stocks present a unique set of attractions for investors, especially investors willing to shoulder some extra risk. To start with, biotech firms have a famously high ov...

Meet the Biotech Stock That Jumped Over 1000% in One Day

Investors looking for some unseemly gains will often pivot to the biotech space, a segment for which the term high-risk/high-reward might possibly have been coined. Bear or bull, it can make no differ...

2 Biotech Stocks Under $10 That Could Win From Key FDA Approvals

The biotech industry can bring investors some truly lucrative gains – but these stocks are not for the faint of heart. The companies bring to the table a combination of famously high overhead and long...

Why Biotech Meat Cannot Compete With Animal Meat At Retail

syringe sticking out of raw chicken getty Even combining cell-cultured meat with plant-based ingredients will still prove impossible to compete with the real thing in the marketplace. Recently, the U....

Top Dividend Stocks: Leading Biotech AbbVie Hikes Payout

IBD’s Income Investor column highlights top dividend stocks. With a long track record of dividend increases, AbbVie (ABBV) is in focus, generating a strong yield with stable fundamentals. X Biop...

Crypto Remains Largest Investment Sector in 2022, Outpacing Fintech And Biotech

Web3 and DeFi are still leading funding activity in the venture capital space, even as deals slow down, according to a new report. Investment in emerging technologies fell for the third consecutive qu...

Biotech Stocks: BioMarin Scores Breakout After FDA Announcement

Biotech stock BioMarin (BMRN) gapped above a buy point and is now trading in a buy zone. X On Wednesday, shares of BioMarin gapped up over 7% in strong volume and traded above a 92.86 buy point. When ...

Is it too late to invest in the Biotech stocks?

“IBB” – the iShares Biotechnology ETF has already recovered about 30% over the past five months but Jefferies’ Michael Yee is convinced it still has more room to the upside. Yee’s bull case for the bi...

Former Silicon Valley Star Elizabeth Holmes Sentenced to Prison

Failed startup founder Elizabeth Holmes received a sentence of over 11 years for the fraud she perpetrated when she duped investors about the effectiveness of a blood testing company. Holmes was sente...

This Biotech Company’s Goal Is To Have A Plant-Based American Flag Fly Over The White House

An American flag made out of corn. Stable Diffusion algorithm. With the midterm elections in the rearview mirror, the lawmakers in Washington, DC, are focusing on the future: the topic of the conversa...

NVAX Stock: Biotech Firestorm Takes Down Novavax Despite Quadrupled Sales

Novavax (NVAX) posted an unexpected third-quarter loss, and NVAX stock yo-yoed Wednesday despite better-than-expected sales. X During the September quarter, Novavax lost $2.15 per share, narrowing fro...

Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023

Clovis Oncology Inc. shares CLVS, -71.62% plunged 75% Wednesday, after the Colorado-based biotech said it will not have sufficient liquidity to maintain operations beyond January of 2023. The company ...

what’s a better way to play the biotech space?

Biotech will continue to outperform the benchmark since the U.S. economy is currently in late-cycle expansion, says Bryn Talkington. She’s a Managing Partner at Requisite Capital Management. Biotech i...